Compare Arko Corp. (ARKO) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arko Corp. vs BridgeBio Pharma Inc — how do they compare? Arko Corp. trades at $4.33 (market cap $493.06M), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is far larger — about 33.2× Arko Corp.'s market cap, and Arko Corp. pays a 2.73% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| ARKO | BBIO | |
|---|---|---|
Market Cap | $493.06M | $16.36B |
Sector | Consumer Cyclical | Health |
52-Week High | $8.64 | $90.17 |
52-Week Low | $3.82 | $47.29 |
Enterprise Value | $2.67B | $18.14B |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arko Corp.
ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
Read more on ARKO →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
